Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Active not recruiting 3Unknown 2Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Gynecologic 2Gastrointestinal 2CNS 2Thoracic 1Other solid neoplasm 1Lymphoid 1Genitourinary 1Dermatologic 1Classical hematology 1Breast 1

Conditions

Endometrial Neoplasms 2Endometrial Hyperplasia 1Colonic Neoplasms 1

Interventions

Paclitaxel 79Cisplatin 72Carboplatin 72Bevacizumab 29Radiotherapy 27Brachytherapy 23Hyperthermic Intraperitoneal Chemotherapy 20Drug Therapy 20olaparib 19Gemcitabine 17niraparib 16apatinib 16pembrolizumab 15Surgical Procedures, Operative 15liposomal doxorubicin 12Cyclophosphamide 12Surveys and Questionnaires 11camrelizumab 10Taxes 10Neoadjuvant Therapy 10fludarabine 9anlotinib 9Etoposide 9Blood Specimen Collection 9Topotecan 8Docetaxel 8Sentinel Lymph Node Biopsy 7Platinum 7Injections 7Cytoreduction Surgical Procedures 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Genetic Testing × Gynecologic × Clear all
NCT03322176 2019-01-23

Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing

Data Collection Analysis Business Management

Unknown
200 enrolled
GastrointestinalGynecologic

Colonic Neoplasms, Endometrial Neoplasms

NCT03338985 2018-01-05

Role of Senescence in the Development of Endometrial Cancer

CHU de Reims

Phase NA Unknown
140 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡